PRVB Gross Margin

The Gross Margin of Provention Bio Inc (PRVB) is 96.03%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

PRVB Gross Margin - Historical Value

Date	Value
2022-12-31	96.03%

PRVB Gross Margin - Peers Comparison

Ticker	Name	Value
BMY	Bristol-Myers Squibb Co	75.26%
CBDX	Curative Biosciences Inc	34.75%
ELAN	Elanco Animal Health Inc	54.88%
GNOM.CN	Gnomestar Craft Inc	-56.86%
INTP	Integrated Pharmaceuticals Inc	64.94%
LLY	Eli Lilly and Co	81.31%
MRK	Merck & Co Inc	80.85%
NXEN	Nexien Biopharma Inc	16.58%
ULUR	Altrazeal Life Sciences Inc	67.97%
BSPK	Bespoke Extracts Inc	40.53%
CHM.CN	Chemistree Technology Inc	25.49%
GSAC		41.20%
ACCA	Acacia Diversified Holdings Inc	4.88%
JNJ	Johnson & Johnson	69.11%
POT.CN	Potent Ventures Inc	5.98%
RLSC.CN	Rise Life Science Corp	6291.29%
RPRX	Royalty Pharma PLC	7775.20%
NOUV	Nouveau Life Pharmaceuticals Inc	7775.20%
CIG.CN	Camarico Investment Group Ltd	-155.74%
NSHS.CN	NanoSphere Health Sciences Inc	7775.20%
SIGO	Sunset Island Group Inc	7775.20%
VOQP	Vioquest Pharmaceuticals Inc	43.57%
ATT.CN	Abattis Bioceuticals Corp	67.62%
CTLT	Catalent Inc	21.75%
ETST	Earth Science Tech Inc	65.49%
MDIN	Northstar Global Business Services Inc	50.00%
RSPI	RespireRx Pharmaceuticals Inc	7775.20%
CXUS	Celexus Inc	13.92%
NGBL	Notis Global Inc	-5.61%
PLSI	Phoenix Life Sciences International Ltd	27.05%
RCPIQ	Rock Creek Pharmaceuticals Inc	-49.60%
SYUP	ANBC Inc	-115.69%
VTRS	Viatris Inc	41.65%
ZTS	Zoetis Inc	70.68%
EAPH	Easton Pharmaceuticals Inc	12.88%
PFE	Pfizer Inc	74.33%